New Marine Fungal Deoxy-14,15-Dehydroisoaustamide Resensitizes Prostate Cancer Cells to Enzalutamide
Marine Drugs · 14.01.2023 · 21 (1) · 54
DOI: 10.3390/md21010054 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, online erschienen am 14.01.2023. Verfasst von Sergey A Dyshlovoy und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Experimental Oncology, Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald-Tumorz…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Prostatic Neoplasms, Castration-Resistant. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Far Eastern Federal University.
Abstract (Originalsprache)
Marine fungi serve as a valuable source for new bioactive molecules bearing various biological activities. In this study, we report on the isolation of a new indole diketopiperazine alkaloid deoxy-14,15-dehydroisoaustamide (1) from the marine-derived fungus Penicillium dimorphosporum KMM 4689 associated with a soft coral. The structure of this metabolite, including its absolute configuration, was determined by HR-MS, 1D and 2D NMR as well as CD data. Compound 1 is a very first deoxyisoaustamide alkaloid possessing two double bonds in the proline ring. The isolated compound was noncytotoxic to a panel of human normal and cancer cell lines up to 100 µM. At the same time, compound 1 resensitized prostate cancer 22Rv1 cells to androgen receptor (AR) blocker enzalutamide. The mechanism of this phenomenon was identified as specific drug-induced degradation of androgen receptor transcription variant V7 (AR-V7), which also resulted in general suppression of AR signaling. Our data suggest that the isolated alkaloid is a promising candidate for combinational therapy of castration resistant prostate cancer, including drug-resistant subtypes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Experimental Oncology, Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald-Tumorzentrum-University Cancer Center Hamburg (UCCH), University Medical Cen…
- Institute of High Technologies and Advanced Materials, Far Eastern Federal University, Vladivostok 690922, Russia.
- G.B. Elyakov Pacific Institute of Bioorganic Chemistry, Far Eastern Branch of the Russian Academy of Sciences, Prospect 100-Letiya Vladivostoka, Vladivostok 690022, Russia.
- Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, 20246 Hamburg, Germany.
ORCID-Profile: Sergey A Dyshlovoy, Olesya I Zhuravleva, Dmitry N Pelageev, Anton N Yurchenko, Carsten Bokemeyer
Förderung
- Far Eastern Federal University
Zitieren
APA
Dyshlovoy, S. A., Zhuravleva, O. I., Hauschild, J., Busenbender, T., Pelageev, D. N., Yurchenko, A. N., Khudyakova, Y. V., Antonov, A. S., Graefen, M., Bokemeyer, C., & von Amsberg, G. (2023). New Marine Fungal Deoxy-14,15-Dehydroisoaustamide Resensitizes Prostate Cancer Cells to Enzalutamide. Marine Drugs, 21(1), 54. https://doi.org/10.3390/md21010054
Vancouver
Dyshlovoy SA, Zhuravleva OI, Hauschild J, Busenbender T, Pelageev DN, Yurchenko AN, et al. New Marine Fungal Deoxy-14,15-Dehydroisoaustamide Resensitizes Prostate Cancer Cells to Enzalutamide. Marine Drugs. 2023;21(1):54. doi:10.3390/md21010054
BibTeX
@article{Dyshlovoy2023,
author = {Dyshlovoy, Sergey A and Zhuravleva, Olesya I and Hauschild, Jessica and Busenbender, Tobias and Pelageev, Dmitry N and Yurchenko, Anton N and Khudyakova, Yuliya V and Antonov, Alexandr S and Graefen, Markus and Bokemeyer, Carsten and von Amsberg, Gunhild},
title = {New Marine Fungal Deoxy-14,15-Dehydroisoaustamide Resensitizes Prostate Cancer Cells to Enzalutamide},
journal = {Marine Drugs},
year = {2023},
volume = {21},
number = {1},
pages = {54},
doi = {10.3390/md21010054}
}
EUVIMED